The Discounted Cash Flow (DCF) valuation of Inhibrx Inc (INBX) is 1,109.29 USD. With the latest stock price at 14.27 USD, the upside of Inhibrx Inc based on DCF is 7673.6%.
Based on the latest price of 14.27 USD and our DCF valuation, Inhibrx Inc (INBX) is a buy. buying INBX stocks now will result in a potential gain of 7673.6%.
| Range | Selected | |
| WACC / Discount Rate | 7.6% - 11.0% | 9.3% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 906.13 - 1,446.94 | 1,109.29 |
| Upside | 6249.9% - 10039.7% | 7673.6% |